Randomized Controlled Trial on Treating Moderately Malnourished Pregnant Women

The study, known as the Mamachiponde study, was conducted in rural Malawi and involved 1,828 pregnant women who received either a ready-to-use supplementary food (RUSF) or a fortified corn-soy blend (CSB+) along with a daily multiple micronutrient antenatal supplement (UNIMMAP) or a daily iron and folic acid (IFA) tablet. The study found that RUSF improved gestational weight gain during treatment for moderate malnutrition more than CSB+ with UNIMMAP, and that the incidence of newborns with birth weight <2.4 kg was lowest in the CSB+ with IFA group. The report presents the study's methodology, results, and conclusions, including subgroup analyses of HIV-infected women and their infants.